AstraZeneca, Pfizer Work Against Strain First Detected In India: UK Study
A study by Public Health England has found that two doses of the AstraZeneca vaccine were 60% effective against symptomatic disease from the variant first found in India. The study also found that the Pfizer-BioNTech vaccine was 88% effective against symptomatic disease from the B.1.617.2 variant, two weeks after the second dose, and 93% effective against the B.1.1.7 or UK variant.
